InvestorsHub Logo
Followers 90
Posts 18132
Boards Moderated 0
Alias Born 09/06/2006

Re: akasidney86 post# 5331

Thursday, 09/11/2008 9:53:41 PM

Thursday, September 11, 2008 9:53:41 PM

Post# of 8473
Not a patent lawyer thank god, but I did have to review patent issues in my previous job (telecom, not biotech).

First, don't assume anything is non-obvious. Can we just mention the Amazon 1-click patent? [Cookies, already in existance, were created for just this type application. All Bezos did was add "shopping checkout" to the state of the art]

But on the issue of defending the patent, hptaxis really misses the boat. Nobody will issue a challange until Pro. is a success (and after the NIH patent has expired). After that, it is trivially easy for RPRX to milk it out for a few years even if that can't defend it.

Also, htaxis goes on ad-nausium about the details of the NIH license agreement. Gee, is this the only in-licensed drug in the world?

Certianly I do consider this a weak patent, but that's not significant enough to stop me from buying in, ONCE they raise their cash.

BTW, how timely for you to arrive on the board hptaxis, just before a financing.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RPRX News